MR-proADM as marker of endotheliitis predicts COVID-19 severity.

Luis García de Guadiana RomualdoMaría Dolores Calvo NievesMaría Dolores Rodríguez MuleroIsmael Calcerrada AlisesMarta Hernández OlivoWysali Trapiello FernándezMercedes González MoralesCristina Bolado JiménezMaría Dolores Albaladejo-OtónHilda Fernández OvalleAndrés Conesa HernándezEugenio Azpeleta ManriqueLuciano Consuegra-SánchezLeonor Nogales MartínPablo Conesa ZamoraDavid Andaluz-Ojeda

Published in: European journal of clinical investigation (2021)

Mid-regional proadrenomedullin was the biomarker with highest performance for prognosis of death and progression to severe disease in COVID-19 patients and represents a promising predictor for both outcomes, which might constitute a potential tool in the assessment of prognosis in early stages of this disease.

Keyphrases

sars cov
coronavirus disease
magnetic resonance
early onset
type diabetes
adipose tissue
metabolic syndrome
skeletal muscle
insulin resistance
drug induced
clinical evaluation